Boy's Childhood Restored by New Haemophilia Treatment

A nine-year-old boy named Dermaine Thompson is experiencing his childhood fully again following revolutionary treatment for haemophilia A on the NHS. Previously, Dermaine required frequent hospital visits due to his condition, which affects blood clotting and causes easy bruising and bleeding. He was part of the XTEND-ed international clinical trial, which has led to a significant reduction in bleeds and hospitalizations.

Dermaine's mother, Tanya, shared that the new treatment, which he now receives weekly at home after she was trained to administer it, has been life-changing. She noted a complete absence of bruises on Dermaine since starting the therapy. This has eased the burden on the family, allowing Dermaine to engage in normal childhood activities and spend more quality time with his siblings and friends.

The breakthrough treatment is now available across the UK, offering renewed hope to families affected by haemophilia A. Birmingham Children's Hospital, a leading UK specialist paediatric centre, spearheaded the international study. Dr. Jayashree Motwani, the consultant haematologist who led the study, confirmed that the treatment substantially improves the quality of life by reducing hospital visits and promoting healthier, happier lives with fewer bleeds.